| 1 |
32268817 | In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome. | 2021 Apr 3 |
1 |
| 2 |
33946220 | Low Plasma Citrate Levels and Specific Transcriptional Signatures Associated with Quiescence of CD34+ Progenitors Predict Azacitidine Therapy Failure in MDS/AML Patients. | 2021 Apr 30 |
1 |
| 3 |
34410592 | NFĸB Targeting in Bone Marrow Mesenchymal Stem Cell-Mediated Support of Age-Linked Hematological Malignancies. | 2021 Dec |
1 |
| 4 |
30607021 | LAMP2 expression dictates azacytidine response and prognosis in MDS/AML. | 2019 Jun |
3 |
| 5 |
30806567 | Azacitidine resistance caused by LAMP2 deficiency: a therapeutic window for the use of autophagy inhibitors in MDS/AML patients? | 2019 May |
3 |
| 6 |
30223454 | Relationship between Altered miRNA Expression and DNA Methylation of the DLK1-DIO3 Region in Azacitidine-Treated Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Myelodysplasia-Related Changes. | 2018 Sep 14 |
2 |
| 7 |
24583533 | Expression of CD25 antigen on CD34+ cells is an independent predictor of outcome in late-stage MDS patients treated with azacitidine. | 2014 Feb 28 |
1 |
| 8 |
25122688 | Longitudinal Analysis of DNA Methylation in CD34+ Hematopoietic Progenitors in Myelodysplastic Syndrome. | 2014 Oct |
1 |
| 9 |
21886171 | Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial. | 2012 Mar |
2 |
| 10 |
19796241 | In vitro myogenic differentiation of human bone marrow-derived mesenchymal stem cells as a potential treatment for urethral sphincter muscle repair. | 2009 Sep |
1 |
| 11 |
19218716 | In vitro cardiogenesis can be initiated in human CD34+ cells. | 2008 Mar-Apr |
1 |
| 12 |
16939808 | Role of cyclic nucleotides in fetal hemoglobin induction in cultured CD34+ cells. | 2006 Sep |
1 |
| 13 |
15769738 | CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells. | 2005 May 20 |
1 |
| 14 |
15495241 | 5-Azacytidine supports the long-term repopulating activity of cord blood CD34(+) cells. | 2004 Nov |
1 |